#272Extended selection 101–300
VACSERA
Egypt · Africa
BiologicsVaccines and biological products
Manufacturing profile
Biologics
Vaccines and biological products
Country: Egypt
Macro-region: Africa
Selection basis
The company is placed in positions 101–300 as a manufacturer, biotech, specialty-pharma, generics or CDMO company with practical relevance to the existing FUZKK catalog.
The Top 300 is a FUZKK atlas priority rather than a single official revenue table. China, India, Israel, the USA and the European scope are excluded because separate atlases already cover them.
Representative manufacturing and QC chain
- 1Cell bank or microbial seed
- 2Upstream culture or fermentation
- 3Clarification and chromatography
- 4UF/DF, formulation and sterile filtration
- 5SEC, CE, LC-MS, ELISA, qPCR and bioassay QC
- 6Biological inputs and seed/cell-bank control
- 7Culture, antigen production or fractionation
- 8Purification and formulation
- 9Sterile filling or lyophilisation
Relevant FUZKK packages
Product/API utilities
Residual Host Cell DNA Quality CheckerResidual Host Protein CheckerVaccine Potency AssessorAdjuvant Aluminum Assay CheckerAdjuvant Adsorption Efficiency Quality CheckerInactivated Vaccine Safety Test Quality CheckerLive Attenuated Vaccine Genetic Stability Quality CheckerPlasma Pool Traceability CheckerPlasma Viral Clearance Evidence CheckerCold Chain Shipping Temperature And MKT Quality Checker
Lumex — instrumental QC
LabEx — laboratory QC
Biologic Aggregate Size Quality CheckerCharge Variant CE Quality CheckerProtein Concentration UV Quality CheckerELISA Bioassay Quality CheckerSPR Binding Affinity Quality CheckerEndotoxin Biologic Product Quality CheckerAutomated Sterility Detection Quality CheckerBacterial Endotoxins LAL Quality CheckerSterility Test Membrane Filtration Quality Checker
Medical Devices — equipment and software lifecycle
Suggested first pilot
- Confirm one real product, method or recurring QC review.
- Record the instrument, export format and current specification.
- Select 3–7 utilities from the map above.
- Run a PASS/FAIL sample and agree the expected output.
- After user validation, expand to other products and sites.
Mapping boundary
The Top 300 is a FUZKK atlas priority rather than a single official revenue table. China, India, Israel, the USA and the European scope are excluded because separate atlases already cover them.
Methodology